[Two patients with CC9 intoxication: unexpected symptoms of a novel synthetic cannabinoid].
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND: Hexahydrocannabinol-C9 (CC9) is a novel synthetic cannabinoid with largely unknown toxicity and clinical effects. CASE DESCRIPTION: We report two patients with CC9 intoxication presenting with atypical and prolonged symptoms, including profound somnolence, bradycardia, neuropsychiatric disturbances, and impaired mobility. Both patients experienced a protracted course lasting up to 90 hours. MANAGEMENT: Treatment was primarily focused on symptom control in a low-stimulus environment. Close monitoring of respiratory function was essential in cases of profound sedation, while benzodiazepines were administered when severe agitation occurred. Activated charcoal combined with a laxative was used in one case and may have contributed to recovery by reducing intestinal reabsorption. CONCLUSION: Clinicians should be alert to the atypical and prolonged course of intoxications caused by new synthetic cannabinoids such as CC9. Early recognition, multidisciplinary consultation, and supportive treatment in a low-stimulus environment are essential.
Fields of Study & Subjects
Forensic Toxicology and Drug Analysis
Poisoning and overdose treatments
Cannabis and Cannabinoid Research
Publication details
- Journal / source
- PubMed
- Volume
- 170
- Publication date
- 31 March 2026
- Language
- NL